MARKER THERAPEUTICS, INC. Research and Development in Process
MARKER THERAPEUTICS, INC. (MRKR) reported Research and Development in Process of $116.04 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2020-03-12
- MARKER THERAPEUTICS, INC. research and development in process for fiscal 2018 was $116.04M.
- MARKER THERAPEUTICS, INC. research and development in process for fiscal 2017 was $0.00.
| Period end | Research and Development in Process 12 month | Research and Development in Process 179 month |
|---|---|---|
| 2018-12-31 | $116.04M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-15 | |
| 2014-06-30 | $612.00K 10-Q · filed 2014-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |